Pulsford A H, Heywood R, Street A E, Majeed S K
Toxicol Lett. 1983 Feb;15(2-3):167-74. doi: 10.1016/0378-4274(83)90211-4.
Venalot, a mixture of coumarin and troxerutin, in the proportion 1 to 6 respectively, was given orally to baboons at dosages of 0, 100, 300 and 1000 mg/kg/day for 26 weeks. Vomiting, usually within 3 h of administration and considered to be of central origin, in addition to vomiting immediately after dosing, was noted in animals receiving 1000 mg/kg/day. At this level, collapse on several occasions in two animals, one of which died, was also observed. Another animal receiving 1000 mg/kg/day was killed for humane reasons following a period of weight loss, reduced appetite and deterioration in body condition. However, no adverse effect on body weight gain, food or water consumption, ophthalmoscopic or electrocardiographic examinations were noted in any other animals during this study. Increased levels of liver function (serum leucine amino-peptidase (LAP), and serum ornithine carbamyl transferase (OCT) were noted during the dosing period, together with slightly increased liver weights terminally for animals receiving 1000 mg/kg/day; however, as no morphological or ultrastructural changes were noted, these findings were considered to be attributable to hypertrophy.
维纳洛(Venalot)是一种香豆素和曲克芦丁的混合物,比例分别为1比6,以0、100、300和1000毫克/千克/天的剂量口服给予狒狒,持续26周。接受1000毫克/千克/天剂量的动物,给药后3小时内通常会出现呕吐,被认为是中枢性的,除了给药后立即呕吐外,还观察到这种情况。在此剂量水平下,两只动物出现了几次虚脱,其中一只死亡。另一只接受1000毫克/千克/天剂量的动物,在体重减轻、食欲下降和身体状况恶化一段时间后,出于人道原因被处死。然而,在本研究期间,其他任何动物均未发现对体重增加、食物或水消耗、眼底镜或心电图检查有不良影响。给药期间观察到肝功能水平升高(血清亮氨酸氨基肽酶(LAP)和血清鸟氨酸氨基甲酰转移酶(OCT)),接受1000毫克/千克/天剂量的动物在实验末期肝脏重量略有增加;然而,由于未观察到形态学或超微结构变化,这些发现被认为是由于肥大所致。